Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia

Author： Walker Alison R.   Klisovic Rebecca B.   Garzon Ramiro   Schaaf Larry J.   Humphries Kristina   Devine Steven M.   Byrd John C.   Grever Michael R.   Marcucci Guido   Blum William  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1304-1308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

By Klisovic Rebecca B.   Blum William   Liu Zhongfa   Xie Zhiliang   Kefauver Cheryl   Huynh Lenguyen   Zwiebel James A.   Devine Steven M.   Byrd John C.   Grever Michael R.   Chan Kenneth K.   Marcucci Guido  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1332-1336

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of tosedostat, a novel, oral agent for elderly patients with relapsed or refractory acute myeloid leukemia: a review of the Phase II OPAL trial

By Mathisen Michael S   Ravandi Farhad  

Future Oncology, Vol. 8, Iss. 4, 2012-04 ,pp. : 351-357

Future Medicine

Access to resources Recommend Favorite

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

By Held Lauren A.   Rizzieri David   Long Gwynn D.   Gockerman Jon P.   Diehl Louis F.   Castro Carlos M. de   Moore Joseph O.   Horwitz Mitchell E.   Chao Nelson J.   Gasparetto Cristina  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 172-176

Informa Healthcare

Access to resources Recommend Favorite

Clinical study of Mito-FLAG regimen in treatment of relapsed acute myeloid leukemia

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 982-986

Spandidos Publications

Access to resources Recommend Favorite

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

By Ogura Michinori   Hatake Kiyohiko   Tobinai Kensei   Uchida Toshiki   Suzuki Tatsuya   Terui Yasuhito   Yokoyama Masahiro   Maruyama Dai   Mori Masakazu   Jewell Roxanne C.   Katsura Koichi   Hotta Tomomitsu  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 5, 2013-05 ,pp. : 466-475

Oxford University Press

Access to resources Recommend Favorite